What I’m Reading Today

Here is what I'm reading in the world of medicine this morning: Barely five months into 2018, investors have placed more Seed and Series A money into biotherapeutics companies than all of last year. Epinephrine auto-injectors: to prescribe or not to prescribe. Do we need Epi-pens? Discovery will impact design of drug delivery systems at … Continue reading What I’m Reading Today

What I’m Reading Today

I hope everyone had a great weekend and are ready to get back into the swing of things.  Here is what I am reading to get my week started: EpiPen shortage tied to Pfizer manufacturing issues The Broad Institute, a nonprofit biomedical institute, is seeking to acquire samples of every drug ever developed to see … Continue reading What I’m Reading Today

What I’m Reading

Here are some articles that caught my eye today: Pharma’s broken business model — Part 2: Scraping the barrel in drug discovery Ecstasy as a Remedy for PTSD? You Probably Have Some Questions.​ Bristol-Myers Squibb and Flatiron to collaborate on real-world data standards for regulatory decisions UCB and Science 37 partner up for virtual, siteless … Continue reading What I’m Reading